Jefferies Group LLC Intercept Pharmaceuticals, Inc. Put Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	SELL	$11.23 - $19.59 $522,195 - $910,935	-46,500 Reduced 82.3%	10,000 $138,000
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $112,300 - $195,900	10,000 New	10,000 $138,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $755,405 - $1.01 Million	-56,500 Closed	0 $0
Q3 2021 Sep 21, 2023	BUY	$12.99 - $20.47 $435,165 - $685,745	33,500 Added 145.65%	56,500 $839,000
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $733,935 - $1.16 Million	56,500 New	56,500 $839,000
Q1 2021 May 14, 2021	SELL	$19.33 - $37.75 $444,589 - $868,250	-23,000 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$24.48 - $42.47 $563,040 - $976,810	23,000 New	23,000 $568,000
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $73,440 - $127,410	-3,000 Reduced 11.54%	23,000 $568,000
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $198,235 - $486,588	-4,100 Reduced 13.62%	26,000 $1.64 Million
Q4 2019 Feb 13, 2020	SELL	$57.36 - $124.1 $17,208 - $37,230	-300 Reduced 0.99%	30,100 $3.73 Million
Q3 2019 Nov 13, 2019	SELL	$58.69 - $80.46 $328,664 - $450,575	-5,600 Reduced 15.56%	30,400 $2.02 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $1.06 Million - $1.64 Million	13,600 Added 60.71%	36,000 $2.87 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $1.41 Million - $1.86 Million	15,400 Added 220.0%	22,400 $2.51 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $600,530 - $885,220	7,000 New	7,000 $706,000
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $3.55 Million - $4.53 Million	-67,300 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $2.1 Million - $2.63 Million	36,100 Added 115.71%	67,300 $3.93 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $1.78 Million - $3.71 Million	31,200	31,200 $1.81 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account